Our mission is to combat dysbiosis* in the human body. To that end, we aim to commercialize antimicrobial peptide therapies to safely restore balance to the gut’s microbial flora and overcoming disease. P4 Microbiome was founded by Johns Hopkins University professors Phillip Phan and Jay Pasricha. The company took over the clinical development of P4M01 from the US Army in February of 2020. Together they recognized the immense potential of this discovery, not only for oral health, but also for solving dysbiosis in the GI tract. Beginning with our gingivitis indication, we will work our way down the gastrointestinal (GI) tract, addressing conditions including small intestinal bacterial overgrowth (SIBO) and irritable bowel syndrome (IBS) by correcting the underlying dysbiosis that drives pathology. *Dysbiosis: A change in the microbial composition, especially in the GI tract, that causes imbalance between beneficial and potentially pathogenic bacteria.
| Website | https://www.p4microbiome.com |
| Employees | View employees |
| Founded | 2020 |
| Address | 704 Quince Orchard Rd Suite 320, Gaithersburg, Maryland 20878, US |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Antimicrobial Peptides, Gut Microbiome, Microbiome Therapeutics, Peptide Therapy, Therapeutic Peptides, Gut Health, Intestinal Microbiome, Gut Microbiota, Microbiome Modulation, Microbial Balance, Gut Microbiome Health |
Looking for a particular P4Microbiome employee's phone or email?
P4Microbiome Questions
P4Microbiome is based in Gaithersburg, Maryland.
Related Companies
